$ACT

Genworth Holdings, Inc. sold $37.1M of ACT

Genworth Holdings, Inc. sold 762,894 shares of Enact Holdings, Inc. (ACT) at $48.65 ($37.12M total) on 2026-09-30.

Original reporting
SEC EDGAR · Genworth Holdings, Inc.
Published Oct 1, 2026, 8:22 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 1, 2026, 8:24 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$ACT
Bearish
high confidence
Mentioned
$ACT
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ACTBearishLow
01

Why it matters

The disclosed sale may prompt short sellers and cause a modest dip in ACT's share price.

02

Market read

New insider sale of $37M in ACT shares could influence short-term price movement.

03

What to watch

Genworth may be reallocating capital for other investments, not necessarily a negative signal for ACT.

Relevance 6/10Novelty 7/10Timing: after-hours filing on 2026-10-01

Background

Form 4 filings disclose insider transactions; a 10% owner selling a sizable block is noteworthy for traders.

Company-level read

Ticker impact

$ACTBearishHigh confidence
Context

10% owner Genworth sold 762,894 shares of Enact Holdings for $37.1M in a Form 4 filing.

Expected impact

likely downward pressure as the market prices in the insider sell

Evidence & confidence

A 10% owner disposing $37M of stock signals possible concerns about valuation, which typically triggers short-term sell pressure.

Market effects

Minimal impact on the broader sector; primarily a company-specific insider transaction.

Limited to U.S. markets where ACT trades.

Low; does not affect global market dynamics.

Counterpoint

The sale could be a routine portfolio rebalancing unrelated to company fundamentals.

Key entities

  • Genworth Holdings, Inc.

    10% owner of Enact Holdings, Inc.

  • Enact Holdings, Inc.

    Issuer of the shares sold.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$ACTMedAI 8/10

Enact (ACT) Q2 2026 Earnings Call Transcript

Enact (ACT) reported Q2 2026 adjusted operating income of $177 million, or $1.26 per diluted share, up from $174 million, or $1.15, in Q2 2025. New insurance written rose 15% to $15 billion. FY2026 capital return guidance was raised to $550 million to $600 million. Management cited $274 billion insurance in force and 161% PMIERs sufficiency.